Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204191
Max Phase: Preclinical
Molecular Formula: C33H42N6O4S
Molecular Weight: 618.80
Associated Items:
ID: ALA5204191
Max Phase: Preclinical
Molecular Formula: C33H42N6O4S
Molecular Weight: 618.80
Associated Items:
Canonical SMILES: Cc1ccc(-c2cccc(S(=O)(=O)N[C@@H](Cc3cccc(C(=N)N)c3)C(=O)N3CCC(NC(=O)NC(C)(C)C)CC3)c2)cc1
Standard InChI: InChI=1S/C33H42N6O4S/c1-22-11-13-24(14-12-22)25-8-6-10-28(21-25)44(42,43)38-29(20-23-7-5-9-26(19-23)30(34)35)31(40)39-17-15-27(16-18-39)36-32(41)37-33(2,3)4/h5-14,19,21,27,29,38H,15-18,20H2,1-4H3,(H3,34,35)(H2,36,37,41)/t29-/m0/s1
Standard InChI Key: QTNZVPFRMKRODX-LJAQVGFWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 618.80 | Molecular Weight (Monoisotopic): 618.2988 | AlogP: 3.92 | #Rotatable Bonds: 9 |
Polar Surface Area: 157.48 | Molecular Species: BASE | HBA: 5 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.04 | CX Basic pKa: 11.47 | CX LogP: 2.82 | CX LogD: 0.91 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.18 | Np Likeness Score: -1.23 |
1. Pilgram O, Keils A, Benary GE, Müller J, Merkl S, Ngaha S, Huber S, Chevillard F, Harbig A, Magdolen V, Heine A, Böttcher-Friebertshäuser E, Steinmetzer T.. (2022) Improving the selectivity of 3-amidinophenylalanine-derived matriptase inhibitors., 238 [PMID:35635944] [10.1016/j.ejmech.2022.114437] |
Source(1):